Concerning OS, over-expression of DDX17 (p = 0.0314), DICER1 (p = 0.0414), DROSHA (p = 0.0436), EIF2C3 (p = 0.0432), TNRC6A (p = 0.0213) and XPO5 (p = 0.0098) was associated with worse prognosis and significantly shorter OS of CRC patients (Figure 1d–i; Supplementary Table S1). Here, DDX17 is linked to colorectal carcinoma.